Management and outcomes of congestive heart failure: A prospective study of hospitalised patients

Medical Journal of Australia

Volumn 168, Issue 3, 1998, Pages 115-118

  Lowe, Julia M ^a,b   Candlish, Paula M ^a   Henry, David A ^b,c   Wlodarcyk, John H ^c   Heller, Richard F ^c,d   Fletcher, Peter J ^c,e  

^a JOHN HUNTER HOSPITAL   (Australia)

^b Department of General Medicine ^*

^c UNIVERSITY OF NEWCASTLE   (Australia)

^d Ctr Clin Epidemiol Biostatist

^e Cardiovascular Medicine

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; AGING; ARTICLE; AUSTRALIA; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDY;

EID: 0032472896     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1998.tb126744.x     Document Type: Article

References (19)

1. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987; 316: 1429-1435.
2. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293-302.
3. Pfeffer MA, Braunwald E, Moye CA, et al. on behalf of the SAVE investigators. The effect of captopril on mortality and morbidity in patients with left ventricular dysfunction following myocardial infarction. Results of the survival and ventricular enlargement (SAVE) trial. N Engl J Med 1991; 327: 669-677.
4. Cohn JN, Archibald OG, Fesche S, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Co-operative Study (V-HeFt). N Engl J Med 1986; 314: 1547-1552.
5. Cohn JN, Johnson G, Ziesch S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991; 325: 303-310.
6. Konstam M, Dracup K, Baker D, et al. Heart failure: evaluation and care of patients with left-ventricular systolic dysfunction clinical practice guideline No. 11. AHCPR Publication No. 94-0612. Rockvill, MD: Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services, June 1994.
7. Bonneux L, Bavendreght JJ, Meeterk K, et al. Estimating clinical morbidity due to ischaemic heart disease and congestive heart failure. The future face of heart failure. Am J Public Health 1994; 84: 20-28.
8. Cowie MR, Moster A, Wood DA, et al. The epidemiology of heart failure Eur Heart J 1997; 18: 208-225.
9. Blyth MB, Lazarus R, Ross D, et al. Burdens and outcomes of hospitalisation for congestive heart failure. Med J Aust 1997; 167: 67-70.
10. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971; 285: 1441-1446.
11. International classification of diseases. 9th revision. Clinical modification (ICD-9-CM). Bethesda, MD: US Department of Health and Human Services, 1989.
12. The Criteria Committee of the New York Heart Association. Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. 8th ed. New York: New York Heart Association/Little, Brown and Company, 1979.
13. Charlson MA, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic co-morbidity in longitudinal studies: development and validation. J Chron Dis 1987; 40: 373-383.
14. SAS [computer program]. Cary, NC: SAS Institute Inc, 1994.
15. Ho KKL, Anderson KM, Kannel WB, et al. Survival after the onset of congestive heart failure in Framingham heart study subjects. Circulation 1993; 88: 107-115.
16. Mohan P, Hii JTY, Whittle RD, et al. Acute heart failure: determinants of outcome. Int J Cardiol 1991; 32: 365-376.
17. Packer M, Bristow MR, Cohn JN, et al. The effect of carvediol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996; 334: 1349-1355.
18. Packer M, O'Connor CM, Ghali JK, et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med 1996; 335: 1107-1114.
19. Marantz PR, Tobin JN, Wassertheil-Smoller S, et al. Prognosis in ischaemic heart disease. Arch Intern Med 1992; 152: 2433-2437.